Skip to main content
logo
Nurix Therapeutics, Inc. (NRIX)
NASDAQ: NRIX · Real-Time Price · USD
9.72
-0.04 (-0.41%)
At close: Oct 13, 2025, 4:00 PM EDT
9.90
+0.18 (1.85%)
After-hours: Oct 13, 2025, 7:50 PM EDT

Nurix Therapeutics Revenue

Nurix Therapeutics had revenue of $7.89M in the quarter ending August 31, 2025, a decrease of -37.29%. This brings the company's revenue in the last twelve months to $83.69M, up 48.32% year-over-year. In the fiscal year ending November 30, 2024, Nurix Therapeutics had annual revenue of $54.55M, down -29.15%.

Revenue (ttm)
$83.69M
Revenue Growth
+48.32%
P/S Ratio
9.58
Revenue / Employee
$292,612
Employees
286
Market Cap
747.31M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Nov 30, 202454.55M-22.44M-29.15%
Nov 30, 202376.99M38.36M99.31%
Nov 30, 202238.63M8.88M29.84%
Nov 30, 202129.75M11.93M66.95%
Nov 30, 202017.82M-13.30M-42.73%
Nov 30, 2019 Pro Pro Pro
Nov 30, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group422.82B
Johnson & Johnson90.63B
Merck & Co.63.62B
AbbVie58.33B
AstraZeneca56.50B
Novartis AG55.19B
Eli Lilly and Company53.26B
Novo Nordisk49.11B
Revenue Rankings

NRIX News

More News